| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/28/2007 | EP1757696A2 Group B streptococcus proteins, and their use |
| 02/28/2007 | EP1757695A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757694A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757693A2 Nucleic acids showing difference in expression between hepatoblastoma and normal liver |
| 02/28/2007 | EP1757692A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA |
| 02/28/2007 | EP1757691A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103 |
| 02/28/2007 | EP1757690A1 Gene encoding guanine nucleotide exchange factor and its gene product |
| 02/28/2007 | EP1757689A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/28/2007 | EP1757688A1 Method of disulfide crosslink forming type in vitro protein synthesis |
| 02/28/2007 | EP1757687A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 02/28/2007 | EP1757686A1 Cell death inducer |
| 02/28/2007 | EP1757685A1 Modified ethylenediamine-n,n' disuccinic acid:ethylenediamine lyase |
| 02/28/2007 | EP1757684A2 A 2,6-beta-D-fructan hydrolase enzyme and processes for using the enzyme |
| 02/28/2007 | EP1757683A1 Method of making a mutated type IIT endonuclease which has nicking activity |
| 02/28/2007 | EP1757682A1 Es cell mutation method and system |
| 02/28/2007 | EP1757679A1 Container for nucleic acid amplification, nucleic acid preparation kit and nucleic acid analyzer |
| 02/28/2007 | EP1757636A1 Polyamide resin and hinged molded articles |
| 02/28/2007 | EP1757622A1 Bivalent IgY antibody constructs for diagnostic and therapeutic applications |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757619A2 Osteoprotegerin in milk |
| 02/28/2007 | EP1757618A2 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 02/28/2007 | EP1757617A1 Ret Ligand (RetL) for stimulating neural and renal growth |
| 02/28/2007 | EP1757616A2 Semaphorin receptors |
| 02/28/2007 | EP1757615A1 Fusion protein for inhibiting cervical cancer |
| 02/28/2007 | EP1757614A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 02/28/2007 | EP1757311A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1757307A1 Method of regenerating follicles by inhibiting gene capable of inhibting follicle formation or activating gene capable of inducing follicle formation |
| 02/28/2007 | EP1757295A1 Peripheral-Type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 02/28/2007 | EP1756573A1 Adsorption agent for nucleic acids containing acid-activated phyllosilicate |
| 02/28/2007 | EP1756318A2 Aptamer-toxin molecules and method for using same |
| 02/28/2007 | EP1756317A2 Methods for identifying risk of osteoarthritis and treatments thereof |
| 02/28/2007 | EP1756304A2 Rnai-based target identification and validation |
| 02/28/2007 | EP1756288A2 Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences |
| 02/28/2007 | EP1756287A2 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| 02/28/2007 | EP1756286A2 Maize multidrug resistance-associated protein polynucleotides and methods of use |
| 02/28/2007 | EP1756285A2 Recombinant constructs for use in reducing gene expression |
| 02/28/2007 | EP1756284A1 Method for modifying plant morphology, biochemistry and physiology comprising expression of cytokinin oxidase in the seeds |
| 02/28/2007 | EP1756283A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 02/28/2007 | EP1756282A1 Improved transformation of soybean |
| 02/28/2007 | EP1756281A2 Method for the preparation of optically active epoxides and vicinal diols from styrene epoxides using enantioselective epoxide hydrolases derived from yeasts |
| 02/28/2007 | EP1756280A1 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
| 02/28/2007 | EP1756279A1 Method for producing l-amino acids by means of recombinant coryneform bacteria with reduced activity asur regulators |
| 02/28/2007 | EP1756278A2 Method of improving t cell receptors |
| 02/28/2007 | EP1756277A2 Quasirandom structure and function guided synthesis methods |
| 02/28/2007 | EP1756276A2 Crustacean expression vector |
| 02/28/2007 | EP1756274A1 Lipolytic enzyme assay |
| 02/28/2007 | EP1756273A1 Signal peptide for producing a polypeptide |
| 02/28/2007 | EP1756159A1 C1q family member proteins with altered immunogenicity |
| 02/28/2007 | EP1756158A1 Method for activating of t cell protein tyrosine phosphatase and therapeutical methods based thereon |
| 02/28/2007 | EP1756157A1 Gerbil neurokinin 1 receptor |
| 02/28/2007 | EP1756154A2 EXPRESSION SYSTEM FOR PREPARING IL-15/Fc FUSION PROTEINS AND ITS USE |
| 02/28/2007 | EP1756150A2 Group 1 mite polypeptide variants |
| 02/28/2007 | EP1756149A1 Live, oral vaccine for protection against shigella dysenteriae serotype 1 |
| 02/28/2007 | EP1756148A2 Insecticidal toxin complex fusion proteins |
| 02/28/2007 | EP1756145A1 Production of polypeptides by improved secretion |
| 02/28/2007 | EP1756138A2 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 02/28/2007 | EP1756137A2 Diagnostic and therapeutic methods and compositions involving pten and breast cancer |
| 02/28/2007 | EP1756136A2 Kits and processes for removing contaminants from nucleic acids in environmental and biological samples |
| 02/28/2007 | EP1755670A2 Methods for treating vascular disease |
| 02/28/2007 | EP1755668A2 Adjuvants |
| 02/28/2007 | EP1755664A2 Prrsv subunit vaccines |
| 02/28/2007 | EP1755654A2 Methods and systems for treatment of neurological diseases of the central nervous system |
| 02/28/2007 | EP1755640A1 Hybrid recombinases for genome manipulation |
| 02/28/2007 | EP1755400A2 Aav mediated gene delivery to cochlear cells |
| 02/28/2007 | EP1713930A4 Rapid screening method of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom |
| 02/28/2007 | EP1507776B1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/28/2007 | EP1471355B1 Method of fixing biomolecule to carrier |
| 02/28/2007 | EP1466972B1 Nucleotide sequences having activity of controlling translation efficiency and utilization thereof |
| 02/28/2007 | EP1466015A4 Bioconjugate-nanoparticle probes |
| 02/28/2007 | EP1401493B1 Subunit vaccines and processes for the production thereof |
| 02/28/2007 | EP1390500A4 Transgenic non-human animals for pharmacological and toxicological studies |
| 02/28/2007 | EP1346041B1 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 02/28/2007 | EP1326995B8 Method for synthesising peptides, peptide mimetics and proteins |
| 02/28/2007 | EP1317551B1 Human phospholipases and polynucleotides encoding the same |
| 02/28/2007 | EP1294760B1 Heliothis glutamate receptor |
| 02/28/2007 | EP1285075B1 Process for the fermentative preparation of l-threonine |
| 02/28/2007 | EP1268830B1 Cell cycle stress-related protein and methods of use in plants |
| 02/28/2007 | EP1254240B1 Hybrid protease with reduced antigenicity and its use |
| 02/28/2007 | EP1250424B1 Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules |
| 02/28/2007 | EP1240317B1 Nucleic acid vaccination |
| 02/28/2007 | EP1239776B1 Surgical needle with weeping tip |
| 02/28/2007 | EP1224310B1 Recombinant adenoviruses preparation and adenovirus banks |
| 02/28/2007 | EP1185631B9 Novel endo-beta-1,4-glucanases |
| 02/28/2007 | EP1175510B1 Mismatch repair detection |
| 02/28/2007 | EP1141205B1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in the active site loop region |
| 02/28/2007 | EP1123313B1 Methods and compositions for the prevention and treatment of anemia |
| 02/28/2007 | EP1085811B1 Broad specificity dna damage endonuclease |
| 02/28/2007 | EP1077999B1 Moraxella catharralis proteins |
| 02/28/2007 | EP1073737B1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/28/2007 | EP1067968B1 Methods for evaluating a compound for its effect on skin |
| 02/28/2007 | EP1055005B1 Quantitative determination of nucleic acid amplification products |
| 02/28/2007 | EP1053347B1 Peptide detection method |
| 02/28/2007 | EP1024827B1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 02/28/2007 | EP1017853B1 Normalized nucleic acid libraries and methods of production thereof |
| 02/28/2007 | EP1005557B1 High expression modules containing two or more tandem copies of a methioninase encoding sequence |
| 02/28/2007 | EP0988387B9 Recombinant construct for enhancement of gene expression in plants |
| 02/28/2007 | EP0945506B1 Proteine avec une activite de suppression du vieillissement |
| 02/28/2007 | EP0911412B1 Vector for gene transfer into plant allowing optional deletion of marker gene |
| 02/28/2007 | EP0909323B1 Helicobacter pylori bacterioferritin |
| 02/28/2007 | EP0888122B1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |